Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) has issued an update.
Rapid Dose Therapeutics has launched its co-branded QuickStrip medical cannabis oral thin film in Brazil after securing regulatory approval from Brazil’s health regulator ANVISA for sublingual and buccal administration formats. The product, developed with Entourage Phytolab and distributed via U.S.-based partner Nexxions, positions RDT among the first to offer an oral dissolvable cannabis strip in Brazil’s fast-growing medical cannabis market.
The QuickStrip platform delivers precisely dosed cannabis via rapidly dissolving films designed to treat chronic pain, anxiety, sleep disorders, and neurological symptoms, offering a discreet, non-combustible alternative to oils and capsules. With Brazil’s recent regulatory reforms expanding cultivation permissions, treatment routes, and patient eligibility, and a market projected to grow strongly through 2034, RDT’s early entry and partnerships aim to establish it as a leading provider of consistent, high-quality cannabis therapies in Latin America’s largest healthcare market.
The most recent analyst rating on (TSE:DOSE) stock is a Sell with a C$0.13 price target. To see the full list of analyst forecasts on Rapid Dose Therapeutics Corp stock, see the TSE:DOSE Stock Forecast page.
Spark’s Take on TSE:DOSE Stock
According to Spark, TipRanks’ AI Analyst, TSE:DOSE is a Neutral.
The score is primarily weighed down by weak financial performance (persistent large losses, negative equity, and ongoing cash burn). Technicals add caution with the stock trading below major moving averages and negative MACD, while valuation is difficult to justify with a negative P/E and no dividend yield data.
To see Spark’s full report on TSE:DOSE stock, click here.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company specializing in innovative drug delivery systems, notably its QuickStrip oral thin film technology. The company focuses on medical cannabis and other active pharmaceutical ingredients, targeting regulated healthcare markets through strategic partnerships and co-branded products.
Average Trading Volume: 37,258
Technical Sentiment Signal: Sell
Current Market Cap: C$19.12M
See more data about DOSE stock on TipRanks’ Stock Analysis page.